HCW Biologics
HCWB • NASDAQ • Stock Fundamentals
HCW Biologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Hing C. Wong, with a market cap of $17.6M.
Market Cap$17.6M
Employees45.0
CEOHing C. Wong
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 7, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
HCW Biologics FAQ
Common questions about HCW Biologics
HCW Biologics (HCWB) has a market capitalization of $17.6M and trades on NASDAQ.
HCW Biologics has approximately 45 employees.